{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:19:13Z","timestamp":1779160753712,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.thromres.2015.10.011","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T00:58:31Z","timestamp":1445389111000},"page":"1059-1066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Inhalational use of antithrombotics in humans: Review of the literature"],"prefix":"10.1016","volume":"136","author":[{"given":"K.","family":"Monagle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hepponstall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mertyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Monagle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Ignjatovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Newall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2015.10.011_bb0005","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/01.CIR.89.1.432","article-title":"History of drugs for thrombotic disease: discovery, development and directions for the future","volume":"89","author":"Mueller","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2015.10.011_bb0010","first-page":"407","article-title":"Preliminary report on post-operative treatment with heparin as a preventative of thrombosis","volume":"79","author":"Crafoord","year":"1937","journal-title":"Acta Chir. Scand."},{"key":"10.1016\/j.thromres.2015.10.011_bb0015","first-page":"163","article-title":"Heparin and the thrombosis of veins following injury","volume":"2","author":"Murray","year":"1937","journal-title":"Surgery"},{"key":"10.1016\/j.thromres.2015.10.011_bb0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.thromres.2015.01.006","article-title":"Topical use of antithrombotics: review of literature","volume":"135","author":"Ng","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2015.10.011_bb0025","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1164\/ajrccm.160.5.9809123","article-title":"Lung deposition and clearance of inhaled (99m)Tc-heparin in healthy volunteers","volume":"160","author":"Bendstrup","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.thromres.2015.10.011_bb0030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1183\/09031936.02.00105202","article-title":"Effect of inhaled heparin on lung function and coagulation in healthy volunteers","volume":"19","author":"Bendstrup","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.thromres.2015.10.011_bb0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00001721-199606000-00008","article-title":"Anticoagulant effects and tissue factor pathway inhibitor after intrapulmonary low-molecular-weight heparin","volume":"7","author":"Harenberg","year":"1996","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2015.10.011_bb0040","first-page":"400","article-title":"Morning vs evening effects of intrapulmonary administration of heparin in healthy men","volume":"30","author":"Markiewicz","year":"1992","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"issue":"Suppl 5","key":"10.1016\/j.thromres.2015.10.011_bb0045","first-page":"603","article-title":"Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects","volume":"58","author":"Scheuch","year":"2007","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.thromres.2015.10.011_bb0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/07420529109063928","article-title":"Heparin as a therapy for atherosclerosis: preliminary observations on the intrapulmonary administration of low-dose heparin in the morning versus evening gauged by its effect on blood variables","volume":"8","author":"Kanabrocki","year":"1991","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.thromres.2015.10.011_bb0055","first-page":"699","article-title":"Nebulized heparin and anabolic steroid in the prevention of postoperative deep vein thrombosis following elective abdominal surgery","volume":"117","author":"Zawilska","year":"1990","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch."},{"key":"10.1016\/j.thromres.2015.10.011_bb0060","series-title":"Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-based Clinical Practice Guidelines","first-page":"6","volume":"133","author":"Geerts","year":"2008"},{"key":"10.1016\/j.thromres.2015.10.011_bb0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00004630-199805000-00004","article-title":"Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin\/N-acetylcystine [correction of acetylcystine] therapy","volume":"19","author":"Desai","year":"1998","journal-title":"J. Burn Care Rehabil."},{"key":"10.1016\/j.thromres.2015.10.011_bb0070","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/cc6894","article-title":"A phase 1 trial of nebulised heparin in acute lung injury","volume":"12","author":"Dixon","year":"2008","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2015.10.011_bb0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/BCR.0b013e31815f596b","article-title":"Use of inhaled heparin\/N-acetylcystine in inhalation injury: does it help?","volume":"29","author":"Holt","year":"2008","journal-title":"J. Burn Care Res."},{"key":"10.1016\/j.thromres.2015.10.011_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/BCR.0b013e318198a268","article-title":"Influence of nebulized unfractionated heparin and N-acetylcysteine in acute lung injury after smoke inhalation injury","volume":"30","author":"Miller","year":"2009","journal-title":"J. Burn Care Res."},{"key":"10.1016\/j.thromres.2015.10.011_bb0085","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.burns.2011.07.019","article-title":"A case report of clinically significant coagulopathy associated with aerosolized heparin and acetylcystein therapy for inhalation injury","volume":"37","author":"Chopra","year":"2011","journal-title":"Burns"},{"key":"10.1016\/j.thromres.2015.10.011_bb0090","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.burns.2011.07.006","article-title":"Safety and potential anticoagulant effects of nebulised heparin in burns patients with inhalational injury at Singapore General Hospital Burns Centre","volume":"37","author":"Yip","year":"2011","journal-title":"Burns"},{"key":"10.1016\/j.thromres.2015.10.011_bb0095","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1160\/TH05-01-0047","article-title":"Developmental haemostasis: impact for clinical haemostasis laboratories","volume":"95","author":"Monagle","year":"2006","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.10.011_bb0100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/rmed.1999.0677","article-title":"Inhaled heparin is effective in exacerbations of asthma","volume":"94","author":"Bendstrup","year":"2000","journal-title":"Respir. Med."},{"key":"10.1016\/j.thromres.2015.10.011_bb0105","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1164\/ajrccm.153.5.8630624","article-title":"Time course of the protective effect of inhaled heparin on exercise-induced asthma","volume":"153","author":"Garrigo","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.thromres.2015.10.011_bb0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJM199307083290204","article-title":"Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin","volume":"329","author":"Ahmed","year":"1993","journal-title":"The New England Journal of Medicine."},{"key":"10.1016\/j.thromres.2015.10.011_bb0115","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/ajrccm.160.2.9812076","article-title":"Prevention of exercise-induced bronchoconstriction by inhaled low molecular weight heparin","volume":"160","author":"Ahmed","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.thromres.2015.10.011_bb0120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/02770909709067224","article-title":"Effect of pretreatment with heparin on pulmonary and cutaneous response","volume":"34","author":"Kalpaklioglu","year":"1997","journal-title":"J. Asthma"},{"key":"10.1016\/j.thromres.2015.10.011_bb0125","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1378\/chest.107.4.1009","article-title":"Effect of inhaled heparin on methacholine-induced bronchial hyperreactivity","volume":"107","author":"Ceyhan","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2015.10.011_bb0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.96.09020217","article-title":"The effect of inhaled heparin on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma","volume":"9","author":"Pavord","year":"1996","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.thromres.2015.10.011_bb0135","first-page":"208","article-title":"Effect of inhaled heparin on adenosine-induced bronchial hyperreactivity","volume":"35","author":"Ceyhan","year":"1997","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2015.10.011_bb0140","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5414\/CPP38446","article-title":"Effect of inhaled low molecular weight heparin on methacholine-induced bronchoconstriction","volume":"38","author":"Ceyhan","year":"2000","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2015.10.011_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/S0091-6749(97)70051-4","article-title":"Time course of changes in adenosine 5`-monophosphate airway responsiveness with inhaled heparin in allergic patients","volume":"99","author":"Polosa","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.thromres.2015.10.011_bb0150","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1345\/aph.10140","article-title":"Effects of heparin on hypertonic potassium chloride-induced bronchoconstriction","volume":"35","author":"Tutluoglu","year":"2001","journal-title":"The Annals of Pharmacotherapy."},{"key":"10.1016\/j.thromres.2015.10.011_bb0155","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1164\/ajrccm.153.6.8665036","article-title":"Effects of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma","volume":"153","author":"Diament","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.thromres.2015.10.011_bb0160","first-page":"59","article-title":"The effect of inhaled heparin on airway responsiveness to histamine and leukotriene D4","volume":"24","author":"Stelmach","year":"2003","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.thromres.2015.10.011_bb0165","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s002280100262","article-title":"Effect of inhaled heparin on water-induced bronchoconstriction in allergic asthmatics","volume":"57","author":"Tranfa","year":"2001","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2015.10.011_bb0170","doi-asserted-by":"crossref","DOI":"10.1542\/peds.109.4.e67","article-title":"Treatment of plastic bronchitis in a Fontan patient with tissue plasminogen activator: a case report and review of the literature","volume":"109","author":"Costello","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.thromres.2015.10.011_bb0175","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00246-008-9312-2","article-title":"Fontan patient with plastic bronchitis treated successfully using aerosolized tissue plasminogen activator: a case report and review of the literature","volume":"30","author":"Do","year":"2009","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.thromres.2015.10.011_bb0180","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.PCC.0000149320.06424.1D","article-title":"Long-term treatment of plastic bronchitis with aerosolized tissue plasminogen activator in a Fontan patient","volume":"6","author":"Wakeham","year":"2005","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.thromres.2015.10.011_bb0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00246-007-9127-6","article-title":"A case of plastic bronchitis presenting 9years after Fontan","volume":"29","author":"Zaccagni","year":"2008","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.thromres.2015.10.011_bb0190","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.athoracsur.2012.04.043","article-title":"Plastic bronchitis after extracardiac Fontan operation","volume":"94","author":"Grutter","year":"2012","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.thromres.2015.10.011_bb0195","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1345\/aph.1R690","article-title":"Use of aerosolized tissue plasminogen activator in the treatment of plastic bronchitis","volume":"47","author":"Lubcke","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.thromres.2015.10.011_bb0200","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1097\/00003246-200006000-00074","article-title":"Plastic bronchitis occurring late after the Fontan procedure: treatment with aerosolized urokinase","volume":"28","author":"Quasney","year":"2000","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.thromres.2015.10.011_bb0205","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1067\/mai.2002.124892","article-title":"Does heparin prophylaxis prevent exacerbations of hereditary angioedema?","volume":"109","author":"Weiler","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.thromres.2015.10.011_bb0210","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1183\/09031936.06.00069005","article-title":"Inhaled heparin in cystic fibrosis Eur","volume":"27","author":"Serisier","year":"2006","journal-title":"Respir. J."},{"key":"10.1016\/j.thromres.2015.10.011_bb0215","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0020-7292(94)02273-2","article-title":"Administration of heparin inhalations for correction of blood antithrombin activity in pregnant women with IDDM","volume":"48","author":"Efimov","year":"1995","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.thromres.2015.10.011_bb0220","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.0954-6820.1936.tb12566.x","article-title":"The influence of intravenous injections of heparin in man on the time of coagulation","volume":"88","author":"Hedenius","year":"1936","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.thromres.2015.10.011_bb0225","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2015.10.011_bb0230","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines","volume":"141","author":"Holbrook","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2015.10.011_bb0235","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2015.10.011_bb0240","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1097\/01.CCM.0000057846.21303.AB","article-title":"Coagulation, fibrinolysis, and fibrin deposition in acute lung injury","volume":"31","author":"Idell","year":"2003","journal-title":"Crit. Care Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815301432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815301432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T15:14:38Z","timestamp":1567264478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384815301432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0049384815301432"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2015.10.011","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhalational use of antithrombotics in humans: Review of the literature","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2015.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2015 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}